Skip to content

Clinical trials

Phase 1 Lupus Erythematosus, Systemic trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 1 Country / region: Belgium Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20131
20151
20231
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting2
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB Pharma2
AstraZeneca1
Bristol-Myers Squibb1
GlaxoSmithKline1
Janssen Research & Development, LLC1
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic8
Arthritis, Rheumatoid4
Autoimmune Diseases3
Connective Tissue Diseases2
Immune System Diseases2
Myositis2
Scleroderma, Systemic2
Skin and Connective Tissue Diseases2
Dermatomyositis1
Dry Eye Syndromes1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.